ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface

Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been proven to be an effective means of decreasing COVID-19 mortality, hospitalization rates, and transmission. One of the vaccines deployed worldwide is ChAdOx1 nCoV-19, which uses an adenovirus vector to drive the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Tao, Mendonça, Luiza, Zhu, Yanan, Howe, Andrew, Radecke, Julika, Shah, Pranav M., Sheng, Yuewen, Krebs, Anna-Sophia, Duyvesteyn, Helen M.E., Allen, Elizabeth, Lambe, Teresa, Bisset, Cameron, Spencer, Alexandra, Morris, Susan, Stuart, David I., Gilbert, Sarah, Zhang, Peijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520439/
https://www.ncbi.nlm.nih.gov/pubmed/37766989
http://dx.doi.org/10.1016/j.isci.2023.107882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520439/
https://www.ncbi.nlm.nih.gov/pubmed/37766989
http://dx.doi.org/10.1016/j.isci.2023.107882

Ejemplares similares